Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders
出版年份 2022 全文链接
标题
Neuroprotection of Cannabidiol, Its Synthetic Derivatives and Combination Preparations against Microglia-Mediated Neuroinflammation in Neurological Disorders
作者
关键词
-
出版物
MOLECULES
Volume 27, Issue 15, Pages 4961
出版商
MDPI AG
发表日期
2022-08-05
DOI
10.3390/molecules27154961
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Use of cannabidiol in the treatment of epilepsy
- (2022) Maria Mazurkiewicz-Bełdzińska et al. Neurologia i Neurochirurgia Polska
- Prophylactic Administration of Cannabidiol Reduces Microglial Inflammatory Response to Kainate-Induced Seizures and Neurogenesis
- (2022) Tanya R. Victor et al. NEUROSCIENCE
- Effects of Cannabidiol and Beta-Caryophyllene Alone or in Combination in a Mouse Model of Permanent Ischemia
- (2021) Cody G. Yokubaitis et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabidiol in the treatment of epilepsy: Current evidence and perspectives for further research
- (2021) Valentina Franco et al. NEUROPHARMACOLOGY
- Impact of Stress on Epilepsy: Focus on Neuroinflammation—A Mini Review
- (2021) Claudia Espinosa-Garcia et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cannabinoid Quinones—A Review and Novel Observations
- (2021) Natalya M. Kogan et al. MOLECULES
- Studies of involvement of G-protein coupled receptor-3 in cannabidiol effects on inflammatory responses of mouse primary astrocytes and microglia
- (2021) Jun Wu et al. PLoS One
- Mechanisms of Drug Resistance in the Pathogenesis of Epilepsy: Role of Neuroinflammation. A Literature Review
- (2021) Elena D. Bazhanova et al. Brain Sciences
- Cannabidiol-dihydroartemisinin conjugates for ameliorating neuroinflammation with reduced cytotoxicity
- (2021) Fanfan Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY
- Neuroinflammation: A Signature or a Cause of Epilepsy?
- (2021) Enrico Pracucci et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Neuroprotection with the Cannabidiol Quinone Derivative VCE-004.8 (EHP-101) against 6-Hydroxydopamine in Cell and Murine Models of Parkinson’s Disease
- (2021) Sonia Burgaz et al. MOLECULES
- Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies
- (2021) Ingrid E. Scheffer et al. JAMA Network Open
- Natural products and analogs as preventive agents for metabolic syndrome via peroxisome proliferator-activated receptors: An overview
- (2021) Carlos Villarroel-Vicente et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Effects of Orally Administered Cannabidiol on Neuroinflammation and Intestinal Inflammation in the Attenuation of Experimental Autoimmune Encephalomyelitis
- (2021) Nicholas Dopkins et al. Journal of Neuroimmune Pharmacology
- Abnormal Cannabidiol Affects Production of Pro-Inflammatory Mediators and Astrocyte Wound Closure in Primary Astrocytic-Microglial Cocultures
- (2020) Julian Cardinal von Widdern et al. MOLECULES
- Secondary Metabolites Profiled in Cannabis Inflorescences, Leaves, Stem Barks, and Roots for Medicinal Purposes
- (2020) Dan Jin et al. Scientific Reports
- The Role of Neuroinflammation in Cellular Damage in Neurodegenerative Diseases
- (2020) Sangu Muthuraju et al. Biomed Research International
- Inflammation in Neurological Disorders: The Thin Boundary Between Brain and Periphery
- (2020) Carlo Cervellati et al. ANTIOXIDANTS & REDOX SIGNALING
- Neuropathic pain: From mechanisms to treatment
- (2020) Nanna Brix Finnerup et al. PHYSIOLOGICAL REVIEWS
- Dihydroartemisinin as a potential drug candidate for cancer therapy: a structural-based virtual screening for multitarget profiling
- (2020) Ibrahim Malami et al. JOURNAL OF BIOMOLECULAR STRUCTURE & DYNAMICS
- Cannabidiol anticonvulsant effect is mediated by the PI3Kγ pathway
- (2020) Isabel Vieira de Assis Lima et al. NEUROPHARMACOLOGY
- Biochemical Aspects and Therapeutic Mechanisms of Cannabidiol in Epilepsy
- (2020) Ana Paula de A. Boleti et al. NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS
- Cannabidiol Treatment for Refractory Epilepsies in Pediatrics
- (2020) Umberto Raucci et al. Frontiers in Pharmacology
- Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?
- (2020) Fangda Leng et al. Nature Reviews Neurology
- Neuroprotective versus Neuroinflammatory Roles of Complement: From Development to Disease
- (2020) Marlene Kanmogne et al. TRENDS IN NEUROSCIENCES
- Cannabinoid therapy in epilepsy
- (2019) Santoshi Billakota et al. CURRENT OPINION IN NEUROLOGY
- Use of Cannabidiol in the Treatment of Epilepsy: Efficacy and Security in Clinical Trials
- (2019) Serena Silvestro et al. MOLECULES
- Microglia-mediated neuroinflammation in neurodegenerative diseases
- (2019) Charannya Sozheesvari Subhramanyam et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome
- (2019) Zinah Z. Al-Ghezi et al. BRAIN BEHAVIOR AND IMMUNITY
- Cannabidiol Adverse Effects and Toxicity
- (2019) Marilyn A. Huestis et al. Current Neuropharmacology
- Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
- (2019) Annamaria Vezzani et al. Nature Reviews Neurology
- Modifiable Risk Factors for Alzheimer’s Disease
- (2019) George A. Edwards III et al. Frontiers in Aging Neuroscience
- Combination of Cannabinoids, Δ9- Tetrahydrocannabinol and Cannabidiol, Ameliorates Experimental Multiple Sclerosis by Suppressing Neuroinflammation Through Regulation of miRNA-Mediated Signaling Pathways
- (2019) Zinah Zamil Al-Ghezi et al. Frontiers in Immunology
- Cannabidiol prevents LPS‐induced microglial inflammation by inhibiting ROS/NF‐κB‐dependent signaling and glucose consumption
- (2019) Mauricio dos‐Santos‐Pereira et al. GLIA
- Schizophrenia—An Overview
- (2019) Robert A. McCutcheon et al. JAMA Psychiatry
- The Effectiveness of Topical Cannabidiol Oil in Symptomatic Relief of Peripheral Neuropathy of the Lower Extremities
- (2019) Dixon H. Xu et al. CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Efficacy and Tolerance of Synthetic Cannabidiol for Treatment of Drug Resistant Epilepsy
- (2019) Kerstin A. Klotz et al. Frontiers in Neurology
- Antioxidative and Anti-Inflammatory Properties of Cannabidiol
- (2019) Sinemyiz Atalay et al. Antioxidants
- Medical cannabis: aligning use to evidence-based medicine approach
- (2018) Lihi Bar-Lev Schleider et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- The non-psychoactive phytocannabinoid cannabidiol (CBD) attenuates pro-inflammatory mediators, T cell infiltration, and thermal sensitivity following spinal cord injury in mice
- (2018) Hongbo Li et al. CELLULAR IMMUNOLOGY
- Long-term safety and treatment effects of cannabidiol in children and adults with treatment-resistant epilepsies: Expanded access program results
- (2018) Jerzy P. Szaflarski et al. EPILEPSIA
- Inflammation in CNS neurodegenerative diseases
- (2018) Jodie Stephenson et al. IMMUNOLOGY
- Sativex® as Add-on therapy Vs. further optimized first-line ANTispastics (SAVANT) in resistant multiple sclerosis spasticity: a double-blind, placebo-controlled randomised clinical trial
- (2018) Jolana Markovà et al. INTERNATIONAL JOURNAL OF NEUROSCIENCE
- Hypoxia mimetic activity of VCE-004.8, a cannabidiol quinone derivative: implications for multiple sclerosis therapy
- (2018) Carmen Navarrete et al. Journal of Neuroinflammation
- Cannabidiol in patients with seizures associated with Lennox-Gastaut syndrome (GWPCARE4): a randomised, double-blind, placebo-controlled phase 3 trial
- (2018) Elizabeth A Thiele et al. LANCET
- Cannabidiol improves frequency and severity of seizures and reduces adverse events in an open-label add-on prospective study
- (2018) Jerzy P. Szaflarski et al. EPILEPSY & BEHAVIOR
- Cannabidiol Attenuates Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis Through Induction of Myeloid-Derived Suppressor Cells
- (2018) David M. Elliott et al. Frontiers in Immunology
- Long-Term Safety, Tolerability, and Efficacy of Cannabidiol in Children with Refractory Epilepsy: Results from an Expanded Access Program in the US
- (2018) Tristan T. Sands et al. CNS DRUGS
- Efficacy and Safety of Cannabidiol in Epilepsy: A Systematic Review and Meta-Analysis
- (2018) Simona Lattanzi et al. DRUGS
- Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial
- (2018) Kerri A. Schoedel et al. EPILEPSY & BEHAVIOR
- Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
- (2018) Ila M. Linares et al. REVISTA BRASILEIRA DE PSIQUIATRIA
- Neuroprotection by cannabidiol and hypothermia in a piglet model of newborn hypoxic-ischemic brain damage
- (2018) Lorena Barata et al. NEUROPHARMACOLOGY
- Insights Into the Neuroinflammatory Responses After Neonatal Hypoxia-Ischemia
- (2017) Malgorzata Ziemka-Nalecz et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Cannabidiol reduces brain damage and improves functional recovery in a neonatal rat model of arterial ischemic stroke
- (2017) Maria Ceprián et al. NEUROPHARMACOLOGY
- Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome
- (2017) Orrin Devinsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Plastic and Neuroprotective Mechanisms Involved in the Therapeutic Effects of Cannabidiol in Psychiatric Disorders
- (2017) Alline C. Campos et al. Frontiers in Pharmacology
- An Overview on Medicinal Chemistry of Synthetic and Natural Derivatives of Cannabidiol
- (2017) Paula Morales et al. Frontiers in Pharmacology
- Inverted U-Shaped Dose-Response Curve of the Anxiolytic Effect of Cannabidiol during Public Speaking in Real Life
- (2017) Antonio W. Zuardi et al. Frontiers in Pharmacology
- Microglial activation and progressive brain changes in schizophrenia
- (2016) L E Laskaris et al. BRITISH JOURNAL OF PHARMACOLOGY
- An update on PPAR activation by cannabinoids
- (2016) Saoirse Elizabeth O'Sullivan BRITISH JOURNAL OF PHARMACOLOGY
- Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise
- (2016) Charu Sharma et al. CURRENT PHARMACEUTICAL DESIGN
- Cannabidiol as a Potential Treatment for Febrile Infection-Related Epilepsy Syndrome (FIRES) in the Acute and Chronic Phases
- (2016) Jacqueline S. Gofshteyn et al. JOURNAL OF CHILD NEUROLOGY
- Cannabidiol, neuroprotection and neuropsychiatric disorders
- (2016) Alline C. Campos et al. PHARMACOLOGICAL RESEARCH
- Cannabis sativa: The Plant of the Thousand and One Molecules
- (2016) Christelle M. Andre et al. Frontiers in Plant Science
- Cannabidiol (CBD) and its analogs: a review of their effects on inflammation
- (2015) Sumner Burstein BIOORGANIC & MEDICINAL CHEMISTRY
- Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol
- (2015) Felipe V. Gomes et al. SCHIZOPHRENIA RESEARCH
- Microglia Development and Function
- (2014) Debasis Nayak et al. Annual Review of Immunology
- Oligodendrocyte-Encoded HIF Function Couples Postnatal Myelination and White Matter Angiogenesis
- (2014) Tracy J. Yuen et al. CELL
- Effects of cannabidiol in the treatment of patients with Parkinson’s disease: An exploratory double-blind trial
- (2014) Marcos Hortes N Chagas et al. JOURNAL OF PSYCHOPHARMACOLOGY
- Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis
- (2014) Manuel A. Friese et al. Nature Reviews Neurology
- Protective Effects of Cannabidiol Against Hippocampal Cell Death and Cognitive Impairment Induced by Bilateral Common Carotid Artery Occlusion in Mice
- (2014) Angélica Pupin Schiavon et al. NEUROTOXICITY RESEARCH
- Hypoxia-Induced Secretion of TGF-β1 in Mesenchymal Stem Cell Promotes Breast Cancer Cell Progression
- (2013) Shun-Pei Hung et al. CELL TRANSPLANTATION
- Cannabidiol provides long-lasting protection against the deleterious effects of inflammation in a viral model of multiple sclerosis: A role for A2A receptors
- (2013) M. Mecha et al. NEUROBIOLOGY OF DISEASE
- Cannabidiol inhibits pathogenic T cells, decreases spinal microglial activation and ameliorates multiple sclerosis-like disease in C57BL/6 mice
- (2011) Ewa Kozela et al. BRITISH JOURNAL OF PHARMACOLOGY
- Neuroinflammation and Neuroprotection: An Update on (Future) Neurotrophin-Related Strategies in Multiple Sclerosis Treatment
- (2011) L. De Santi et al. CURRENT MEDICINAL CHEMISTRY
- Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study
- (2011) Lourdes Ruiz-Valdepeñas et al. Journal of Neuroinflammation
- Cannabidiol and Other Cannabinoids Reduce Microglial Activation In Vitro and In Vivo: Relevance to Alzheimer's Disease
- (2011) A. M. Martin-Moreno et al. MOLECULAR PHARMACOLOGY
- Neural basis of anxiolytic effects of cannabidiol (CBD) in generalized social anxiety disorder: a preliminary report
- (2010) José Alexandre S Crippa et al. JOURNAL OF PSYCHOPHARMACOLOGY
- A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis
- (2010) C. Collin et al. NEUROLOGICAL RESEARCH
- Cannabinoids Δ9-Tetrahydrocannabinol and Cannabidiol Differentially Inhibit the Lipopolysaccharide-activated NF-κB and Interferon-β/STAT Proinflammatory Pathways in BV-2 Microglial Cells
- (2009) Ewa Kozela et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis
- (2008) Celia J. A. Morgan et al. BRITISH JOURNAL OF PSYCHIATRY
- Neuroprotective Effects of the Nonpsychoactive Cannabinoid Cannabidiol in Hypoxic-Ischemic Newborn Piglets
- (2008) Francisco J Alvarez et al. PEDIATRIC RESEARCH
- Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons
- (2008) S. Guo et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started